Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis

  • Jeffrey J. Swigris
  • , David L. Streiner
  • , Kevin K. Brown
  • , Amanda Belkin
  • , Kathy E. Green
  • , Frederick S. Wamboldt
  • , M. Schwarz
  • , D. A. Zisman
  • , G. Hunninghake
  • , J. Chapman
  • , M. Olman
  • , S. Lubell
  • , L. D. Morrison
  • , M. P. Steele
  • , T. Haram
  • , J. Roman
  • , R. Perez
  • , T. Perez
  • , J. H. Ryu
  • , J. P. Utz
  • A. H. Limper, C. E. Daniels, K. Meiras, S. Walsh, K. K. Brown, M. Schwarz, C. Bair, D. Kervitsky, J. A. Lasky, S. Ditta, J. De Andrade, V. J. Thannickal, M. Stewart, D. A. Zisman, J. Lynch, E. Calahan, P. Lopez, T. E. King, H. R. Collard, J. A. Golden, P. J. Wolters, R. Jeffrey, I. Noth, D. K. Hogarth, N. Sandbo, M. E. Strek, S. R. White, C. Brown, I. Garic, S. Maleckar, F. J. Martinez, K. R. Flaherty, M. Han, B. Moore, G. B. Toews, D. Dahlgren, G. Raghu, J. Hayes, M. Snyder, J. E. Loyd, L. Lancaster, W. Lawson, R. Greer, W. Mason, R. J. Kaner, V. Monroy, M. Wang, D. A. Lynch, T. Colby, K. J. Anstrom, R. C. Becker, E. L. Eisenstein, N. R. MacIntyre, L. D. Morrison, J. Rochon, M. P. Steele, J. S. Sundy, L. Davidson-Ray, P. Dignacco, R. Edwards, R. Anderson, R. Beci, S. Calvert, K. Cain, T. Gentry-Bumpass, D. Hill, M. Ingham, E. Kagan, J. Kaur, C. Matti, J. McClelland, A. Meredith, T. Nguyen, J. Pesarchick, R. S. Roberts, W. Tate, T. Thomas, J. Walker, D. Whelan, J. Winsor, Q. Yang, E. Yow, H. Y. Reynolds, X. Tian, J. Kiley

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Dyspnea is a hallmark symptom of idiopathic pulmonary fibrosis (IPF), and dyspnea induced physical activity limitation is a prominent driver of quality of life impairment among IPF patients. Methods: We examined response data for the 21 physical activity items (the first 21 of 24) from the University of California San Diego Shortness of Breath Questionnaire (UCSD) collected at baseline in a recently conducted IPF trial. We used Rasch analysis and hypothesis testing with conventional statistical methodology to achieve three objectives: 1) to examine the items to identify the one characteristic that distinguishes one from another; 2) to asses these items for their ability to measure dyspnea severity in IPF; 3) to use the items to develop a dyspnea ruler. Results: The sample comprised 178 subjects. The 21 items fit the Rasch model. There was very strong correlation between Rasch item severity and their metabolic equivalents (METS) values (r = -0.86, p < 0.0001). With the sample stratified on scores from the 21 items, there were significant between group differences in FVC%, DLCO% and distance walked during the six-minute walk test. The dyspnea ruler can be used to put dyspnea levels in a more easily understood clinical context. Conclusions: The first 21 items from the UCSD compose a unidimensional dyspnea-with-activity scale and are both sensibly ordered and distinguished from each other by their METS values. These 21 items can be used confidently to formulate clinically-relevant inferences about IPF patients and should be considered for use as a meaningful endpoint in IPF research.

Original languageEnglish (US)
Pages (from-to)181-188
Number of pages8
JournalRespiratory Medicine
Volume108
Issue number1
DOIs
StatePublished - Jan 2014

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Cite this